Smidfelt K, Drott C, Törngren K, Nordanstig J, Herlitz J, Langenskiöld M
Department of Vascular Surgery and Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska University Hospital and Academy, Blå stråket 5, 413 46 Gothenburg, Sweden.
Department of Surgery Borås hospital, 50182 Borås, Sweden.
Eur J Vasc Endovasc Surg. 2017 Jul;54(1):21-27. doi: 10.1016/j.ejvs.2017.03.022. Epub 2017 May 16.
OBJECTIVE/BACKGROUND: To investigate the frequency of initial misdiagnosis and the clinical consequences of an initial misdiagnosis of ruptured abdominal aortic aneurysms (rAAA).
This was a retrospective cohort study. Data from the Swedish National Registry for Vascular Surgery (Swedvasc) and medical charts were extracted for patients treated for rAAA in the West of Sweden in the period 2008-14. Initially misdiagnosed patients were compared with correctly diagnosed patients.
In all, 261 patients were included in the study. Patients with rAAA were initially misdiagnosed in 33% (n = 86) of the cases and this caused a 4.8 hour (median time) additional delay to surgical intervention. There were no differences in 30 day mortality between initially misdiagnosed patients and correctly diagnosed patients (27.9% vs. 28.0%; p = 1.00). The adjusted odds ratio for mortality in initially misdiagnosed patients compared with correctly diagnosed patients was 0.78 (95% confidence interval 0.38-1.60). No difference was observed between the groups regarding 90 day mortality, length of intensive care, need for post-operative ventilator support, need of haemodialysis support, and length of hospital stay.
Misdiagnosis is common in patients with rAAA, and treatment is significantly delayed in misdiagnosed patients. The study did not show any survival disadvantage or increased frequency of post-operative complications in misdiagnosed patients despite the delayed treatment. However, only patients who reached surgical intervention were included in the analysis.
目的/背景:探讨腹主动脉瘤破裂(rAAA)初始误诊的发生率及其临床后果。
这是一项回顾性队列研究。提取了瑞典国家血管外科注册中心(Swedvasc)的数据以及2008 - 2014年期间在瑞典西部接受rAAA治疗患者的病历。将初始误诊患者与正确诊断患者进行比较。
该研究共纳入261例患者。rAAA患者中33%(n = 86)的病例被初始误诊,这导致手术干预额外延迟4.8小时(中位时间)。初始误诊患者与正确诊断患者的30天死亡率无差异(27.9%对28.0%;p = 1.00)。与正确诊断患者相比,初始误诊患者死亡的调整优势比为0.78(95%置信区间0.38 - 1.60)。两组在90天死亡率、重症监护时长、术后呼吸机支持需求、血液透析支持需求以及住院时长方面均未观察到差异。
rAAA患者中误诊很常见,误诊患者的治疗会显著延迟。尽管治疗延迟,但该研究未显示误诊患者有任何生存劣势或术后并发症发生率增加。然而,分析中仅纳入了接受手术干预的患者。